EUVIMEDEUVIMED entdecken
Crossref

Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL‐induced activation of NF‐κB and MAPK signaling pathways and ROS

Jian Huang, Dezhi Song, Minglian Xu, Kai Gan, Chaofeng Wang, Liuyuan Chen, Qian Huang, Junchun Chen, Yuangang Su, Jiake Xu iD, Jinmin Zhao, Qian Liu iD

Phytotherapy Research · 2024

DOI: 10.1002/ptr.8299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, 2024. Verfasst von Jian Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: MAP Kinase Signaling System, Osteoclasts, Osteolysis, Reactive Oxygen Species. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangxi Science and Technology Base and Talent Special Project, Guangxi Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory osteolysis is often caused by the excessive activation of osteoclasts stimulated by bacterial products such as lipopolysaccharide. The natural flavonoid trifolirhizin (TRI) has anti‐inflammatory properties; however, its function in inflammatory bone lysis remains unclear. This study aimed to elucidate the potential regulatory mechanisms of TRI in osteoclasts.Tartrate‐resistant acid phosphatase (TRAP) staining, acid secretion assays, podosomal actin belt fluorescence staining, and bone resorption assays were used to investigate the effects of TRI on osteoclast differentiation and bone resorption. A reactive oxygen species (ROS) measurement kit was used to detect the effect of TRI on ROS levels in osteoclasts. The effects of TRI on genes and signaling pathways related to osteoclast differentiation were determined by quantitative polymerase chain reaction (qPCR) and western blotting. A mouse model of lipopolysaccharide‐mediated inflammatory osteolysis was established, and the effects of TRI treatment on bone mass were observed using micro‐CT and histological examination. Mechanistically, TRI reduced ROS production by inhibiting receptor activator of nuclear factor‐κB ligand (RANKL)‐induced activation of the nuclear factor‐κB (NF‐κB) and mitogen‐activated protein kinase (MAPK) signaling pathways, and by upregulating the expression levels of the anti‐ROS enzymes heme oxygenase‐1 (HO‐1) and catalase (CAT), which contributed to the degradation of ROS, ultimately leading to a decrease in osteoclastogenesis. TRI inhibited osteoclast formation and ameliorated lipopolysaccharide (LPS)‐mediated inflammatory osteolysis. Thus, TRI may be a candidate agent for anti‐inflammatory osteolysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MAP Kinase Signaling SystemOsteoclastsOsteolysisReactive Oxygen SpeciesGlucosidesHeterocyclic Compounds, 4 or More RingsAnimalsMaleMiceBone ResorptionCell DifferentiationLipopolysaccharidesMice, Inbred C57BLNF-kappa BRANK LigandRAW 264.7 CellsSignal Transduction

Stichwörter der Autor:innen

MAPKNF‐κBROSinflammatory osteolysisosteoclasttrifolirhizin

Substanzen

LipopolysaccharidesNF-kappa BRANK LigandReactive Oxygen SpeciestrifolirhizinGlucosidesHeterocyclic Compounds, 4 or More Rings

Autor:innen und Institutionen

  • Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Sciences Institute, Guangxi Medical University, Nanning, Chi…
  • Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.

ORCID-Profile: Jiake Xu, Qian Liu

Förderung

  • National Natural Science Foundation of China
  • Guangxi Science and Technology Base and Talent Special Project
  • Guangxi Natural Science Foundation
  • Specific Research Project of Guangxi for Research Bases and Talents
  • Natural Science Foundation of Guangxi Zhuang Autonomous Region

Zitieren

APA

Huang, J., Song, D., Xu, M., Gan, K., Wang, C., Chen, L., Huang, Q., Chen, J., Su, Y., Xu, J., Zhao, J., & Liu, Q. (2024). Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL‐induced activation of NF‐κB and MAPK signaling pathways and ROS. Phytotherapy Research. https://doi.org/10.1002/ptr.8299

Vancouver

Huang J, Song D, Xu M, Gan K, Wang C, Chen L, et al. Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL‐induced activation of NF‐κB and MAPK signaling pathways and ROS. Phytotherapy Research. 2024. doi:10.1002/ptr.8299

BibTeX
@article{Huang2024,
  author = {Huang, Jian and Song, Dezhi and Xu, Minglian and Gan, Kai and Wang, Chaofeng and Chen, Liuyuan and Huang, Qian and Chen, Junchun and Su, Yuangang and Xu, Jiake and Zhao, Jinmin and Liu, Qian},
  title = {Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL‐induced activation of NF‐κB and MAPK signaling pathways and ROS},
  journal = {Phytotherapy Research},
  year = {2024},
  doi = {10.1002/ptr.8299}
}
Kostenlos starten →